Skip Navigation

Vaccine Safety Bibliography - April 2011

1.   General thoughts on HPV vaccination. J Am Osteopath Assoc. 2011 Mar; 111(3 Suppl 2):S2.

2.   NASN position statement: immunizations. NASN Sch Nurse. 2011 Mar; 26(2):121-2.

3.   Outbreak news. Meningococcal disease,Chad. Wkly Epidemiol Rec. 2011 Mar 18; 86(12):101.

4.   Outbreak news. Yellow fever, Sierra Leone. Wkly Epidemiol Rec. 2011 Mar 18; 86(12):101-2.

5.   Progress in interrupting wild poliovirus circulation in countries with re-established transmission:Africa, 2009-2010. Wkly Epidemiol Rec. 2011 Mar 18; 86(12):104-10.

6.   Aagaard L, Hansen EW, Hansen EH. Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade. Eur J Clin Pharmacol. 2011 Mar; 67(3):283-8.

7.   Aboal Beato MA, Martínez Suárez M, Castrillón Piñeiro LM, Juncal Fondevila AR. [Protective tetanus antibody titres and new re-vaccination requirements.]. Aten Primaria. 2011 Mar 10. [Epub ahead of print].

8.   Ahmed GY, Balkhy HH, Bafaqeer S, Al-Jasir B, Althaqafi A. Acceptance and Adverse Effects of H1N1 Vaccinations Among a Cohort of National Guard Health Care Workers during the 2009 Hajj Season. BMC Res Notes. 2011 Mar 13;4:61.

9.   Al-Mendalawi MD, Basaleem HO. Immunization coverage and its determinants among children 12-23 months of age in Aden, Yemen. Saudi Med J. 2011 Mar; 32(3):318.

10.  Alecsandru D, Valor L, Sánchez-Ramón S, Gil J, Carbone J, Navarro J, Rodríguez JJ, Rodríguez-Sainz C, Fernández-Cruz E. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4(+) T cells and impact on clinical outcome. Clin Exp Immunol. 2011 Mar 10. [Epub ahead of print].

11.  Altamirano-Diaz L, West L, Humar A, Ely L, Urschel S, Gubbay J, Crowcroft N, Kumar D. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Pediatr Transplant. 2011 Mar; 15(2):172-5.

12.  At'kov OY, Azarov AV, Zhukov DA, Nicoloyannis N, Durand L. Influenza vaccination in healthy working adults in Russia: observational study of effectiveness and return on investment for the employer. Appl Health Econ Health Policy. 2011 Mar 1; 9(2):89-99.

13.  Atchison C, Lopman B, John Edmunds W. Modelling the seasonality of rotavirus  disease and the impact of vaccination in England and Wales. Vaccine. 2011 Mar 21. [Epub ahead of print].

14.  Azevedo RS, Amaku M. Modelling immunization strategies with cytomegalovirus vaccine candidates. Epidemiol Infect. 2011 Mar 14:1-9. [Epub ahead of print].

15.  Babouee B, Widmer AF, Battegay M. [Vaccination against pneumococci and influenza : How good is the evidence?]. Internist (Berl). 2011 Mar; 52(3):265-276.

16.  Banaszkiewicz A, Radzikowski A. More on Vaccinations in IBD Patients. Am J Gastroenterol. 2011 Mar; 106(3):545-6.

17.  Bardenheier B, Shefer A, Ahmed F, Remsburg R, Rowland Hogue CJ, Gravenstein S. Do Vaccination Strategies Implemented by Nursing Homes Narrow the Racial Gap in Receipt of Influenza Vaccination in the United States? J Am Geriatr Soc. 2011 Mar 25. [Epub ahead of print].

18.  Becker-Dreps S, Paniagua M, Dominik R, Cao H, Shah NK, Morgan DR, Moreno G,

Espinoza F. Changes in childhood diarrhea incidence in nicaragua following 3 years of universal infant rotavirus immunization. Pediatr Infect Dis J. 2011 Mar; 30(3):243-7.

19.  Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, Wald A, Poland G, Jacobson R, Keyserling HL, Spearman P, Hill H, Wolff M; National Institute of Allergy and Infectious Diseases-Funded Vaccine and Treatment Evaluation Units. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis. 2011 Mar 1; 203(5):666-73.

20.  Bernard DM, Cooper Robbins SC, McCaffery KJ, Scott CM, Skinner SR. The domino effect: adolescent girls' response to human papillomavirus vaccination. Med JAust. 2011 Mar 21; 194(6):297-300.

21.  Betsch C, Ulshöfer C, Renkewitz F, Betsch T. The Influence of Narrative v. Statistical Information on Perceiving Vaccination Risks. Med Decis Making. 2011 Mar 29. [Epub ahead of print].

22.  Biai S, Rodrigues A, Nielsen J, Sodemann M, Aaby P. Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. Vaccine. 2011 Mar 24. [Epub ahead of print].

23.  Birmingham E, Catallozzi M, Findley SE, Vawdrey DK, Kukafka R, Stockwell MS. FluAlert: A qualitative evaluation of providers' desired characteristics and concerns regarding computerized influenza vaccination alerts. Prev Med. 2011 Mar-Apr; 52(3-4):274-7.

24.  Blank F, Stumbles P, von Garnier C. Opportunities and challenges of the pulmonary route for vaccination. Expert Opin Drug Deliv. 2011 Mar 26. [Epub ahead of print].

25.  Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM. Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review. Pharmacoeconomics. 2011 Mar 1; 29(3):199-211.

26.  Brown VL, Jane White KA. The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study. Math Biosci. 2011 Mar 4. [Epub ahead of print]. 

27.  Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R,

Bines JE; for the PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization  Program in Australia. Vaccine. 2011 Mar 7. [Epub ahead of print].

28.  Bärnighausen T, Bloom DE, Canning D, Friedman A, Levine OS, O'Brien J, Privor-Dumm L, Walker D. Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine. Vaccine. 2011 Mar 16; 29(13):2371-80.

29.  Chan KH, To KK, Hung IF, Zhang AJ, Chan JF, Cheng VC, Tse H, Che XY, Chen H, Yuen KY. Differences in the antibody response between individuals with natural infection of and vaccination against pandemic H1N1 2009 influenza. Clin Vaccine Immunol. 2011 Mar 16. [Epub ahead of print].

30.  Chandran SA, Ramachandra SS, Sekhar PS. National Family Health Survey-3 reported, low full-immunization coverage rates in Andhra Pradesh, India: who is to be blamed? J Public Health (Oxf). 2011 Mar 15. [Epub ahead of print].

31.  Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2011 Mar 16; 3:CD007795.

32.  Conway JH, Green T. Childhood immunization policies and the prevention of communicable disease. Pediatr Ann. 2011 Mar; 40(3):136-43.

33. Cristina C, Marco T, Pasquale P, Alessandro S, Francesco M, Gianmarco S, Paola M, Veronica C, Matteo F, Luca A, Corrado B. Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district. Vaccine. 2011 Mar 9. [Epub ahead of print].

34.  D'Agaro P, Molin GD, Gallo T, Rossi T, Santon D, Busetti M, Comar M, Campello C. Epidemiological and molecular assessment of a measles outbreak in a highly vaccinated population of northeast Italy. Epidemiol Infect. 2011 Mar 14:1-7. [Epub ahead of print].

35.  d'Onofrio A, Manfredi P, Poletti P. The impact of vaccine side effects on the natural history of immunization programmes: an imitation-game approach. J Theor Biol. 2011 Mar 21; 273(1):63-71.

36.  Dempsey AF, Schaffer SE. Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines. Prev Med. 2011 Mar-Apr; 52(3-4):268-9.

37.  Dubé E, Gilca V, Sauvageau C, Bradet R, Bettinger JA, Boulianne N, Boucher FD, McNeil S, Gemmill I, Lavoie F. Canadian paediatricians' opinions on rotavirus vaccination. Vaccine. 2011 Mar 2. [Epub ahead of print].

38.  Ernst E. Anthroposophy: a risk factor for noncompliance with measles immunization. Pediatr Infect Dis J. 2011 Mar; 30(3):187-9.

39.  Esteghamati A, Keshtkar A, Heshmat R, Gouya MM, Salar Amoli M, Armin S, Mahoney F. Adverse Reactions Following Immunization with MMR Vaccine in Children at Selected Provinces of Iran. Arch Iran Med. 2011 Mar; 14(2):91-5.

40.  Fabio V, Daniele F, Monica de D, Simone G, Luciana MM, Margherita O, Massimiliano B, Rene D, Piero M, Fabrizio S, Ugo B. Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: a report of two cases.  Transpl Int. 2011 Mar; 24(3):e28-9.

41.  Fadnes LT, Nankabirwa V, Sommerfelt H, Tylleskär T, Tumwine JK, Engebretsen IM; for the PROMISE-EBF Study Group. Is vaccination coverage a good indicator of  age-appropriate vaccination? A prospective study from Uganda. Vaccine. 2011 Mar 11. [Epub ahead of print].

42.  Gagneur A, Nowak E, Lemaitre T, Segura JF, Delaperrière N, Abalea L, Poulhazan E, Jossens A, Auzanneau L, Tran A, Payan C, Jay N, de Parscau L, Oger E; The IVANHOE investigators. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study. Vaccine. 2011 Mar 25. [Epub ahead of print].

43.  Galemore CA. Immunization information systems--progress on integration of school nurses: a multi-state roundtable. NASN Sch Nurse. 2011 Mar; 26(2):83-6.

44.  Grant LA, Dunne EF, Chesson H, Markowitz LE. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Vaccine. 2011 Mar 16; 29(13):2365-70.

45.  Grgic-Vitek M, Klavs I. Low coverage and predictors of vaccination uptake against tick-borne encephalitis in Slovenia. Eur J Public Health. 2011 Mar 11. [Epub ahead of print].

46.  Hayward AC, Watson J. Effectiveness of influenza vaccination of staff on morbidity, and mortality of residents of long term care facilities for the elderly. Vaccine. 2011 Mar 16; 29(13):2357-8.  

47.  Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr. 2011 Mar; 65(3):329-34.

48.  Helms C, Polgreen P, Polgreen L, Evans T, Roberts LL, Clabaugh G, Quinlisk P. Voluntary reporting of employee influenza vaccination rates by acute care hospitals in Iowa: The impact of a four year provider-based statewide performance improvement project. Vaccine. 2011 Mar 22. [Epub ahead of print].

49.  Hofmann C, Baur MO, Schroten H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol. 2011 Mar; 258(3):500-1.

50.  Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011 Mar; 17(3):434-8.

51.  Izadi M, Afsharpaiman S, Jonaidi Jafari N, Ranjbar R, Gooya MM, Robat Sarpooshi J, Esfahani AA, Soheylipoor H. Immunization status of Iranian military  recruits against Bordetella pertussis infection (whooping cough). J Infect Dev Ctries. 2011 Mar 21; 5(3):224-6.

52.  Jit M, Bilcke J, Mangen MJ, Salo H, Melliez H, Edmunds WJ, Yazdanpanah Y, Beutels P. Response to comment on article by Jit et al. "The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe". Vaccine. 2011 Mar 14. [Epub ahead of print].

53.  Joesoef MR, Leung J, Harpaz R, Bialek SR. Potential coding error of herpes zoster (HZ) vaccination and HZ diagnosis in administrative data. Vaccine. 2011 Mar 3; 29(11):2008-9.

54.  Judge EP, Hannan MM, McCarthy JF, Egan JJ. Delayed diagnosis of novel H1N1 influenza pneumonitis in a vaccinated heart transplant recipient. J Heart Lung Transplant. 2011 Mar; 30(3):357-8.

55.  Kennedy A, Sapsis KF, Stokley S, Curtis CR, Gust D. Parental attitudes toward human papillomavirus vaccination: evaluation of an educational intervention, 2008. J Health Commun. 2011 Mar; 16(3):300-13.

56.  Kennedy LH, Pruitt R, Smith K, Garrell RF. Closing the immunization gap. Nurse Pract. 2011 Mar; 36(3):39-45.

57.  Kharbanda EO, Stockwell MS, Fox H, Ipp LS, Rickert VI. The Role of Human Papillomavirus Vaccination in Promoting Delivery of Other Preventive and Medical Services. Acad Pediatr. 2011 Mar 9. [Epub ahead of print].

58.  Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine. 2011 Mar 21;29(14):2537-41.

59.  Kieninger-Baum DM, Zepp F. [Vaccination in adults.]. Internist (Berl). 2011 Mar; 52(3):239-249.

60.  Kristjánsdóttir Ó, Kristjánsdóttir G. Randomized clinical trial of musical distraction with and without headphones for adolescents' immunization pain. Scand J Caring Sci. 2011 Mar; 25(1):19-26.

61.  Kuhnert R, Hecker H, Poethko-Müller C, Schlaud M, Vennemann M, Whitaker HJ, Farrington CP. A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med. 2011 Mar 15; 30(6):666-77.

62.  Kumar VM, Whynes DK. Explaining variation in the uptake of HPV vaccination in England. BMC Public Health. 2011 Mar 22; 11(1):172. [Epub ahead of print].

63.  Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis. 2011 Mar; 15(3):e206-10.

64.  Lazarus R, Clutterbuck E, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, Pollard AJ. A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults. Clin Infect Dis. 2011 Mar; 52(6):736-42.

65.  Lee BY, Bacon KM, Donohue JM, Wiringa AE, Bailey RR, Zimmerman RK. From thepatient perspective: The economic value of seasonal and H1N1 influenza vaccination. Vaccine. 2011 Mar 3; 29(11):2149-58.

66.  Levine H, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Zarka S, Balicer RD. Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy. Vaccine. 2011 Mar 24; 29(15):2785-90.

67.  Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors Associated with Intention to Vaccinate a Daughter against HPV: A Statewide Survey in Alabama. J Pediatr Adolesc Gynecol. 2011 Mar 11. [Epub ahead of print].

68.  Mato Chaín G, Mariano Lázaro A, Alcudia Pérez F, Verdejo Bravo C. [Flu vaccination in the elderly.]. Rev Esp Geriatr Gerontol. 2011 Mar 7. [Epub ahead of print].

69.  Matsui D, Shigeta M, Ozasa K, Kuriyama N, Watanabe I, Watanabe Y. Factors associated with influenza vaccination status of residents of a rural community in Japan. BMC Public Health. 2011 Mar 4; 11:149.

70.  Meier S, Bel M, L'huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA; with the H1N1 Epidemiology Study Group of Geneva. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine. 2011 Mar 16. [Epub ahead of print].

71.  Mercer G, Kelly H. Seasonal influenza vaccination and the 2009 pandemic. Clin Infect Dis. 2011 Mar; 52(6):828-9.

72.  Merikukka M, Kaasila M, Namujju PB, Palmroth J, Kirnbauer R, Paavonen J, Surcel HM, Lehtinen M. Differences in incidence and co-occurrence of vaccine and  nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. Int J Cancer. 2011 Mar 1; 128(5):1114-9.

73.  Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine. 2011 Mar 12. [Epub ahead of print].

74.  Middleman AB, Tung JS. School-located immunization programs: Do parental preferences predict behavior? Vaccine. 2011 Mar 14. [Epub ahead of print].

75.  Miller EK, Dumitrescu L, Cupp C, Dorris S, Taylor S, Sparks R, Fawkes D, Frontiero V, Rezendes AM, Marchant C, Edwards KM, Crawford DC. Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age. Vaccine. 2011 Mar 25. [Epub ahead of print].

76.  Miura K, Zhou H, Diouf A, Tullo G, Moretz SE, Aebig JA, Fay MP, Miller LH, Doumbo OK, Sagara I, Dicko A, Long CA, Ellis RD. Immunological responses against  Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized. Vaccine. 2011 Mar 9; 29(12):2255-61.

77.  Miyakis S, Giannakaki V, Moustakidis E, Trelopoulou A, Trakatelli C, Kotsis V, Sion M. Vaccination against 2009 pandemic H1N1 influenza among healthcare workers in a tertiary hospital: rates, reasoning, beliefs. J Hosp Infect. 2011 Mar 14. [Epub ahead of print].

78.  Moraga-Llop FA. [Pneumococcal vaccination. Beyond childhood.]. Med Clin (Barc). 2011 Mar 11. [Epub ahead of print].

79.  National Association of Pediatric Nurse Practitioners. NAPNAP position statement on immunizations. J Pediatr Health Care. 2011 Mar-Apr; 25(2):e6-8.

80.  Niemi E, Korppi M. Parapneumonic empyema in children before the era of pneumococcal vaccination. Acta Paediatr. 2011 Mar 28. [Epub ahead of print].

81.  O'Mahony LN, Klein EJ, Walker W. A Fully Immunized Child With a Cochlear Implant and Streptococcus pneumoniae Meningitis 3 Years After Implantation. Pediatr Emerg Care. 2011 Mar; 27(3):200-2.

82.  Ori E, Sharon A, Ella M, Mitchell S, Itamar G, Jonathan W, Uri A, Ayelet B, Daphna P, David L, Irena W, Dan C, Michal M. The efficacy and safety of vaccination against pandemic 2009 influenza a (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken). 2011 Mar 18. [Epub ahead of print].

83.  Palmeiro JK, De Carvalho NS, Botelho AC, Fracalanzza SE, Madeira HM, Dalla-Costa LM. Maternal group B streptococcal immunization: Capsular polysaccharide (CPS)-based vaccines and their implications on prevention. Vaccine. 2011 Mar 14. [Epub ahead of print].

84.  Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med. 2011 Mar; 24(3):402-6.

85.  Parretta E, Ianniello B, Ferrazin F, Rossi F, Capuano A. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. Vaccine. 2011 Mar 12. [Epub ahead of print].

86.  Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine. 2011 Mar 24; 29(15):2791-6.

87.  Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine. 2011 Mar 21; 29(14):2613-8.

88.  Pedersen G, Halstensen A, Sjursen H, Naess A, Kristoffersen EK, Cox RJ. Pandemic Influenza Vaccination Elicits Influenza Specific CD4+ Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports. Scand J Immunol. 2011 Mar 25. [Epub ahead of print].

89.  Pezzoli L, Tchio R, Dzossa AD, Ndjomo S, Takeu A, Anya B, Ticha J, Ronveaux O, Lewis RF. Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009. Epidemiol Infect. 2011 Mar 22:1-13. [Epub ahead of print].

90.  Pirrotta MT, Bernardeschi P, Fiorentini G. A case of acquired haemophilia following H1N1 vaccination. Haemophilia. 2011 Mar 30. [Epub ahead of print].

91.  Poethko-Müller C, Atzpodien K, Schmitz R, Schlaud M. [Suspected adverse reactions after vaccination. Results from the German Health Interview and Examination Survey for Children and Adolescents. Part 2: predictors of parental reporting of suspected adverse reactions after vaccinations]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Mar; 54(3):365-71.

92.  Poethko-Müller C, Atzpodien K, Schmitz R, Schlaud M. [Suspected adverse reactions after vaccination. Results from the German Health Interview and Examination Survey for Children and Adolescents. Part I: descriptive analyses].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Mar; 54(3):357-64.

93.  Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after  vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines.  2011 Mar; 10(3):307-22.

94.  Pírez MC, Algorta G, Cedrés A, Sobrero H, Varela A, Giachetto G, Montano A.  Impact of Universal Pneumococcal Vaccination on Hospitalizations for Pneumonia and Meningitis in Children in Montevideo, Uruguay. Pediatr Infect Dis J. 2011 Mar 14. [Epub ahead of print].

95.  Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in Pediatric Rotavirus-related Hospitalizations After Universal Rotavirus Vaccination in Belgium. Pediatr Infect Dis J. 2011 Mar 23. [Epub ahead of print].

96.  Riley M, Locke AB, Skye EP. Health Maintenance in School-aged Children: PartI. History, Physical Examination, Screening, and Immunizations. Am Fam Physician. 2011 Mar 15;83(6):683-8.

97.  Roberts SA, Brabin L, Stretch R, Baxter D, Elton P, Kitchener H, McCann R. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect. 2011 Mar; 139(3):400-5.

98.  Roukens AH, Gelinck LB, Visser LG. Intradermal Vaccination to Protect Against Yellow Fever and Influenza. Curr Top Microbiol Immunol. 2011 Mar 17. [Epub ahead of print].

99.   Sato N, Watanabe K, Ohta K, Tanaka H. Acute Transverse Myelitis and Acute Motor Axonal Neuropathy Developed after Vaccinations against Seasonal and 2009 A/H1N1 Influenza. Intern Med. 2011; 50(5):503-7.

100. Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: Coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant. 2011 Mar 26. [Epub ahead of print].

101. Septimus EJ, Perlin JB, Cormier SB, Moody JA, Hickok JD. A multifaceted mandatory patient safety program and seasonal influenza vaccination of health care workers in community hospitals. JAMA. 2011 Mar 9; 305(10):999-1000.

102. Serpa JA, Valayam J, Musher DM, Rossen RD, Pirofski LA, Rodriguez-Barradas MC. VH3 Antibody Response to Immunization with Pneumococcal Polysaccharide Vaccine in Middle-Aged and Elderly Persons. Clin Vaccine Immunol. 2011 Mar; 18(3):362-6.

103. Simon JK, Maciel M Jr, Weld ED, Wahid R, Pasetti MF, Picking WL, Kotloff KL, Levine MM, Sztein MB. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri  2a oral vaccine candidates. Clin Immunol. 2011 Mar 7. [Epub ahead of print].

104. Stroud C, Altevogt BM, Butler JC, Duchin JS. The Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events: Regional Workshop Series on the 2009 H1N1 Influenza Vaccination Campaign. Disaster Med Public Health Prep. 2011 Mar; 5(1):81-6.

105. Tabache F, El Kartouti A, Naitlhou A, Hassikou H, Tarib A, Baaj M, Cherrah Y. Acute polyarthritis after influenza A (H1N1) immunization. Joint Bone Spine. 2011 Mar 26. [Epub ahead of print].

106. Tchuenche JM, Khamis SA, Agusto FB, Mpeshe SC. Optimal control and sensitivity analysis of an influenza model with treatment and vaccination. Acta Biotheor. 2011 Mar; 59(1):1-28.

107. Teresa DC, Miguel VJ, Susana C, Ana G, Gregoria L, Ignacio MF. 2009-2010 seasonal and pandemic A (H1N1) influenza vaccination among healthcare workers. Vaccine. 2011 Mar 21. [Epub ahead of print].

108.  Torrieri-Dramard L, Lambrecht B, Ferreira HL, Van den Berg T, Klatzmann D, Bellier B. Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses. Mol Ther. 2011 Mar; 19(3):602-11.

109. Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Reverbel Da Silveira T, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez Ayala SE, De León T, Van Doorn LJ, Pilar Rubio MD, Suryakiran PV, Casellas JM, Ortega-Barria E, Smolenov IV, Han HH; the Rota-024 Study Group. Human Rotavirus Vaccine Is Highly Efficacious When Coadministered With Routine Expanded Program of Immunization Vaccines Including Oral Poliovirus Vaccine in Latin America. Pediatr Infect Dis J. 2011 Mar 3. [Epub ahead of print].

110. Trollfors B, Dotevall L, Sundh V, Welinder-Olsson C. Pertussis after end of a mass vaccination project-End of the "vaccination honey-moon". Vaccine. 2011 Mar 16; 29(13):2444-50.

111. Troy SB, Ferreyra Reyes L, Huang C, Mahmud N, Lee YJ, Canizales Quintero S, Flaster H, Baez Saldaña R, García-García L, Maldonado Y. Use of a Novel Real-Time PCR Assay to Detect Oral Polio Vaccine (OPV) Shedding and Reversion in Stool and Sewage Samples after a Mexican National Immunization Day. J Clin Microbiol. 2011 Mar 16. [Epub ahead of print].

112. Usman HR, Rahbar MH, Kristensen S, Vermund SH, Kirby RS, Habib F, Chamot E. Randomized controlled trial to improve childhood immunization adherence in rural Pakistan: redesigned immunization card and maternal education. Trop Med Int Health. 2011 Mar; 16(3):334-42.

113. van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011 Mar; 70(3):414-22.

114. van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P. Ag85B-ESAT-6 adjuvanted with IC31(®) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine. 2011 Mar 3; 29(11):2100-9.

115. Vietri JT, Chapman GB, Li M, Galvani AP. Preferences for HPV vaccination in  parent-child dyads: Similarities and acknowledged differences. Prev Med. 2011 Mar 22. [Epub ahead of print].

116. Virgili G, Turchetti G, Gusinu R, Gensini GF. Commentary on: Economic evaluation of human papilloma virus vaccination in the European Union: a critical review. Intern Emerg Med. 2011 Apr; 6(2):157-8.

117. Ward K, Seale H, Zwar N, Leask J, Macintyre CR. Annual influenza vaccination: coverage and attitudes of primary care staff in Australia. Influenza Other Respi Viruses. 2011 Mar; 5(2):135-41.

118. Weisser M. [Vaccination under immunosuppressive therapy of chronic inflammatory diseases.]. Internist (Berl). 2011 Mar; 52(3):277-282.

119.  Wells CR, Tchuenche JM, Meyers LA, Galvani AP, Bauch CT. Impact of Imitation Processes on the Effectiveness of Ring Vaccination. Bull Math Biol. 2011 Mar 16. [Epub ahead of print].

120.  White KE, Pabst LJ, Cullen KA. Up-to-Date Haemophilus influenzae Type b Vaccination Coverage During a Vaccine Shortage. Pediatrics. 2011 Mar; 127(3):e707-12.

121. Wilson K, Hawken S, Potter BK, Chakraborty P, Kwong J, Crowcroft N, Rothwell D, Manuel D. Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations-A population based study of 969,519 vaccination events. Vaccine. 2011 Mar 25. [Epub ahead of print].

122. Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr Opin Infect Dis. 2011 Mar 16. [Epub ahead of print].

123. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLoS Med. 2011 Mar;8(3):e1001012.

 [top]